Cargando…

Importance of Opioid Agonist Therapy to Reduce Injection-Related Infections

Detalles Bibliográficos
Autores principales:	Weaver, Victoria K, Kennedy, Mary Clare
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154324/ https://www.ncbi.nlm.nih.gov/pubmed/35663287 http://dx.doi.org/10.1093/ofid/ofac145

Ejemplares similares

Breastfeeding on Injectable Opioid Agonist Therapy: A Case Report
por: Patricelli, Charissa J., et al.
Publicado: (2023)

Perinatal Injectable Opioid Agonist Therapy (iOAT) Administration: A Case Series
por: Patricelli, Charissa J., et al.
Publicado: (2023)

Magnesium sulphate intravenously reduces tachycardia side-effects of β(2)-agonists
por: Sellers, William F.S., et al.
Publicado: (2022)

Reply to: Magnesium sulphate intravenously reduces tachycardia side-effects of β(2)-agonists
por: Powell, Colin, et al.
Publicado: (2022)

Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy
por: Janjua, Naveed Z., et al.
Publicado: (2019)

Sustained Virologic Response in People Who Inject Drugs and/or Who Are on Opioid Agonist Therapy: Is 90% Enough?
por: Naggie, Susanna, et al.
Publicado: (2019)

Opioids and the COVID-19 pandemic: does chronic opioid use or misuse increase clinical vulnerability?
por: Lambert, David G.
Publicado: (2020)

Unequal access to opioid agonist treatment and sterile injecting equipment among hospitalized patients with injection drug use-associated infective endocarditis
por: Brothers, Thomas D., et al.
Publicado: (2022)

Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors
por: Shen, Qianwei, et al.
Publicado: (2017)

Long-term follow up of clients from a community-based opioid substitution therapy programme in Manipur
por: Kermode, Michelle, et al.
Publicado: (2011)

Implications of hedonic effects of opioids in clinical practice
por: Blatt, Jonathan M.
Publicado: (2022)

Inhaled therapy reduces COPD mortality
por: Andreas, Stefan, et al.
Publicado: (2020)

Sex work involvement among women with long-term opioid injection drug dependence who enter opioid agonist treatment
por: Marchand, Kirsten, et al.
Publicado: (2012)

Quinine Sulphate for Intramuscular Injections
por: Shah, K. A.
Publicado: (1945)

Better agonist for the opioid receptors
por: Badshah, Syed Lal, et al.
Publicado: (2018)

Important co-infections in the first wave of COVID-19 pandemic in India
por: Subhadra, Subhra, et al.
Publicado: (2022)

First Case of Laboratory-confirmed Zika Virus Infection Imported into China
por: Zhong, Yuan-Bin, et al.
Publicado: (2016)

Further defining and conceptualizing opioid misuse in chronic pain
por: Voon, Pauline
Publicado: (2015)

Opioids for Sedation: Has the Pendulum Swung Too Far?
por: Murray, Brian P., et al.
Publicado: (2021)

Pembrolizumab combined with low-dose cyclophosphamide and intra-tumoral injection of the toll-like receptor 4 agonist G100 in patients with advanced pretreated soft tissue sarcoma: results from the PEMBROSARC basket study
por: Spalato-Ceruso, Mariella, et al.
Publicado: (2022)

Gabapentinoid-related deaths: An alarming global trend or just a special challenge within the long tail of the giant opioid epidemic?
por: Bonnet, Udo, et al.
Publicado: (2022)

Therapeutic potential of long-acting opioids and opioid antagonists for SARS-CoV-2 infection
por: Eagleton, Marie, et al.
Publicado: (2021)

Salvarsan Injections
por: Iyengar, S. V. Ramaswamy
Publicado: (1916)

Glucose Injection
Publicado: (1949)

Glucose Injection
por: Sen, A.
Publicado: (1948)

Service delivery models for injectable opioid agonist treatment in Canada: 2 sequential environmental scans
por: Eydt, Erin, et al.
Publicado: (2021)

Declines in Depressive Symptoms Among People who Inject Drugs Treated With Direct-Acting Antivirals While on Opioid Agonist Therapy
por: Pericot-Valverde, Irene, et al.
Publicado: (2020)

Access to tablet injectable opioid agonist therapy in rural and smaller urban settings in British Columbia, Canada: a qualitative study
por: Bardwell, Geoff, et al.
Publicado: (2023)

Detection sensitivity of ultrasound scanning vs. clinical examination for insulin injection-related lipohypertrophy
por: Yu, Jian, et al.
Publicado: (2022)

Opioid agonist treatment scale-up and the initiation of injection drug use: A dynamic modeling analysis
por: Marks, Charles, et al.
Publicado: (2019)

The SMILES trial: an important first step
por: Jacka, Felice N., et al.
Publicado: (2018)

The upcoming synthetic ultrapotent opioid wave as a foreseeable disaster
por: Krausz, R Michael, et al.
Publicado: (2022)

Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details
por: Vozoris, Nicholas T.
Publicado: (2021)

PCSK6: The Endogenous PAR-1 Agonist Driving Pulmonary Fibrosis?
por: Spek, C. Arnold, et al.
Publicado: (2023)

Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs
por: Bornebusch, Annika Billefeld, et al.
Publicado: (2019)

Notes on the Hypodermic Injection of Quinine in Malarial Fevers
por: Barnett, K. Bruce
Publicado: (1902)

Saline Injection in Cholera
por: Das, Bhagwan
Publicado: (1915)

Intravenous Injection of Quinine
por: Brodribb, C.
Publicado: (1915)

Injections of Cyanide of Mercury
por: Williamson, J. Rutter
Publicado: (1915)

Intracerebral Injection of Antivenine
por: Atal, P.
Publicado: (1900)

Cannot write session to /tmp/vufind_sessions/sess_e5qv2pp85e4i36t5k80vkmspnj